Patents by Inventor Julio Argentieri

Julio Argentieri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220305237
    Abstract: A needle-injection catheter includes a catheter body having a distal end, a proximal end, a stiff proximal portion, a flexible distal portion, and a delivery lumen extending therethrough. In a first embodiment, a straight injection needle extends coaxially from a distal tip of the flexible portion of the catheter body, and a plurality of penetration limiting elements positioned circumferentially about a base of the straight injection needle and configured to fold radially inwardly against a shaft of the needle when constrained in a tubular lumen and to extend radially outwardly when unconstrained. In a second embodiment, a helical needle extends from the distal tip of the flexible portion of the catheter body. The helical needle has at least one helical delivery lumen connected to receive an injectable substance from the delivery lumen of the catheter body.
    Type: Application
    Filed: June 2, 2022
    Publication date: September 29, 2022
    Applicant: BioCardia, Inc.
    Inventors: Wai Hsueh, Olin Jay Palmer, Scott Comiso, James B. Ross, Ken Vien, Julio Argentieri, Peter Altman
  • Publication number: 20200398029
    Abstract: A needle-injection catheter includes a catheter body having a distal end, a proximal end, a stiff proximal portion, a flexible distal portion, and a delivery lumen extending therethrough. In a first embodiment, a straight injection needle extends coaxially from a distal tip of the flexible portion of the catheter body, and a plurality of penetration limiting elements positioned circumferentially about a base of the straight injection needle and configured to fold radially inwardly against a shaft of the needle when constrained in a tubular lumen and to extend radially outwardly when unconstrained. In a second embodiment, a helical needle extends from the distal tip of the flexible portion of the catheter body. The helical needle has at least one helical delivery lumen connected to receive an injectable substance from the delivery lumen of the catheter body.
    Type: Application
    Filed: September 2, 2020
    Publication date: December 24, 2020
    Applicant: BioCardia, Inc.
    Inventors: Wai Hsueh, Olin Jay Palmer, Scott Comiso, James B. Ross, Ken Vien, Julio Argentieri, Peter Altman
  • Patent number: 10780248
    Abstract: A needle-injection catheter includes a catheter body having a distal end, a proximal end, a stiff proximal portion, a flexible distal portion, and a delivery lumen extending therethrough. In a first embodiment, a straight injection needle extends coaxially from a distal tip of the flexible portion of the catheter body, and a plurality of penetration limiting elements positioned circumferentially about a base of the straight injection needle and configured to fold radially inwardly against a shaft of the needle when constrained in a tubular lumen and to extend radially outwardly when unconstrained. In a second embodiment, a helical needle extends from the distal tip of the flexible portion of the catheter body. The helical needle has at least one helical delivery lumen connected to receive an injectable substance from the delivery lumen of the catheter body.
    Type: Grant
    Filed: August 9, 2018
    Date of Patent: September 22, 2020
    Assignee: BioCardia, Inc.
    Inventors: Wai Hsueh, Olin Jay Palmer, Scott Comiso, James B. Ross, Ken Vien, Julio Argentieri, Peter Altman
  • Publication number: 20180344986
    Abstract: A needle-injection catheter includes a catheter body having a distal end, a proximal end, a stiff proximal portion, a flexible distal portion, and a delivery lumen extending therethrough. In a first embodiment, a straight injection needle extends coaxially from a distal tip of the flexible portion of the catheter body, and a plurality of penetration limiting elements positioned circumferentially about a base of the straight injection needle and configured to fold radially inwardly against a shaft of the needle when constrained in a tubular lumen and to extend radially outwardly when unconstrained. In a second embodiment, a helical needle extends from the distal tip of the flexible portion of the catheter body. The helical needle has at least one helical delivery lumen connected to receive an injectable substance from the delivery lumen of the catheter body.
    Type: Application
    Filed: August 9, 2018
    Publication date: December 6, 2018
    Inventors: Wai Hsueh, Olin Jay Palmer, Scott Comiso, James B. Ross, Ken Vien, Julio Argentieri, Peter Altman
  • Patent number: 10071226
    Abstract: A needle-injection catheter includes a catheter body having a distal end, a proximal end, a stiff proximal portion, a flexible distal portion, and a delivery lumen extending therethrough. In a first embodiment, a straight injection needle extends coaxially from a distal tip of the flexible portion of the catheter body, and a plurality of penetration limiting elements positioned circumferentially about a base of the straight injection needle and configured to fold radially inwardly against a shaft of the needle when constrained in a tubular lumen and to extend radially outwardly when unconstrained. In a second embodiment, a helical needle extends from the distal tip of the flexible portion of the catheter body. The helical needle has at least one helical delivery lumen connected to receive an injectable substance from the delivery lumen of the catheter body.
    Type: Grant
    Filed: September 30, 2014
    Date of Patent: September 11, 2018
    Assignee: BioCardia, Inc.
    Inventors: Wai Hsueh, Olin Jay Palmer, Scott Comiso, James B. Ross, Ken Vien, Julio Argentieri, Peter Altman
  • Publication number: 20170266107
    Abstract: A method of treating chronic post-myocardial infarction including helical needle transendocardial delivery of autologous bone marrow (ABM) mononuclear cells around regions of hypo or akinesia in chronic post-myocardial infarction (MI) patients. The treatment is safe and improves ejection fraction (EF).
    Type: Application
    Filed: November 2, 2016
    Publication date: September 21, 2017
    Inventors: Luis M. de la Fuente, Simon H. Stertzer, Julio Argentieri, Eduardo Penaloza, Peter A. Altman
  • Patent number: 9517199
    Abstract: A method of treating chronic post-myocardial infarction including helical needle transendocardial delivery of autologous bone marrow (ABM) mononuclear cells around regions of hypo or akinesia in chronic post-myocardial infarction (MI) patients. The treatment is safe and improves ejection fraction (EF).
    Type: Grant
    Filed: February 24, 2015
    Date of Patent: December 13, 2016
    Assignee: BioCardia, Inc.
    Inventors: Luis M. de la Fuente, Simon H. Stertzer, Julio Argentieri, Eduardo Penaloza, Peter A. Altman
  • Patent number: 9504642
    Abstract: A method of treating chronic post-myocardial infarction including helical needle transendocardial delivery of autologous bone marrow (ABM) mononuclear cells around regions of hypo or akinesia in chronic post-myocardial infarction (MI) patients. The treatment is safe and improves ejection fraction (EF).
    Type: Grant
    Filed: July 30, 2013
    Date of Patent: November 29, 2016
    Assignee: BioCardia, Inc.
    Inventors: Luis M. de la Fuente, Simon H. Stertzer, Julio Argentieri, Eduardo Penaloza, Peter A. Altman
  • Publication number: 20150231368
    Abstract: A needle-injection catheter includes a catheter body having a distal end, a proximal end, a stiff proximal portion, a flexible distal portion, and a delivery lumen extending therethrough. In a first embodiment, a straight injection needle extends coaxially from a distal tip of the flexible portion of the catheter body, and a plurality of penetration limiting elements positioned circumferentially about a base of the straight injection needle and configured to fold radially inwardly against a shaft of the needle when constrained in a tubular lumen and to extend radially outwardly when unconstrained. In a second embodiment, a helical needle extends from the distal tip of the flexible portion of the catheter body. The helical needle has at least one helical delivery lumen connected to receive an injectable substance from the delivery lumen of the catheter body.
    Type: Application
    Filed: September 30, 2014
    Publication date: August 20, 2015
    Applicant: BioCardia, Inc.
    Inventors: Wai Hsueh, Olin Jay Palmer, Scott Comiso, James B. Ross, Ken Vien, Julio Argentieri, Peter Altman
  • Publication number: 20150164786
    Abstract: A method of treating chronic post-myocardial infarction including helical needle transendocardial delivery of autologous bone marrow (ABM) mononuclear cells around regions of hypo or akinesia in chronic post-myocardial infarction (MI) patients. The treatment is safe and improves ejection fraction (EF).
    Type: Application
    Filed: February 24, 2015
    Publication date: June 18, 2015
    Applicant: BioCardia, Inc.
    Inventors: Luis M. de la Fuente, Simon H. Stertzer, Julio Argentieri, Eduardo Penaloza, Peter A. Altman
  • Publication number: 20130323212
    Abstract: A method of treating chronic post-myocardial infarction including helical needle transendocardial delivery of autologous bone marrow (ABM) mononuclear cells around regions of hypo or akinesia in chronic post-myocardial infarction (MI) patients. The treatment is safe and improves ejection fraction (EF).
    Type: Application
    Filed: July 30, 2013
    Publication date: December 5, 2013
    Applicant: BioCardia, Inc.
    Inventors: Luis M. de la Fuente, Simon H. Stertzer, Julio Argentieri, Eduardo Penaloza, Peter A. Altman
  • Patent number: 8496926
    Abstract: A method of treating chronic post-myocardial infarction including helical needle transendocardial delivery of autologous bone marrow (ABM) mononuclear cells around regions of hypo or akinesia in chronic post-myocardial infarction (MI) patients. The treatment is safe and improves ejection fraction (EF).
    Type: Grant
    Filed: April 16, 2007
    Date of Patent: July 30, 2013
    Assignee: BioCardia, Inc.
    Inventors: Luis M. de la Fuente, Simon H. Stertzer, Julio Argentieri, Eduardo Penaloza, Peter A. Altman
  • Publication number: 20090148415
    Abstract: A method of treating chronic post-myocardial infarction including helical needle transendocardial delivery of autologous bone marrow (ABM) mononuclear cells around regions of hypo or akinesia in chronic post-myocardial infarction (MI) patients. The treatment is safe and improves ejection fraction (EF).
    Type: Application
    Filed: April 16, 2007
    Publication date: June 11, 2009
    Inventors: Luis M. de la Fuente, Simon H. Stertzer, Julio Argentieri, Eduardo Penaloza, Peter A. Altman